Alpaslan TANOĞLU, Tolga DÜZENLİ, Taner AKYOL

Evaluation of serum CXC chemokine ligand 16 (CXCL16) as a novel inflammatory biomarker or familial Mediterranean fever disease

Background/aim: Familial Mediterranean fever (FMF) is a disease that is mainly diagnosed with clinical features. Several wellknown inflammatory markers increase in FMF. However, there is still a need for diagnostic tests for specifying FMF and monitoring inflammatory activity. CXCL16 is a chemokine produced by inflammatory cells that demonstrate efficacy in the acute phase response. In this study, we aimed to investigate the relationship between CXCL16 levels and FMF disease and to evaluate CXCL16 levels as a novel biomarker for FMF. Materials and methods: Fifty-three male patients diagnosed with FMF and sixty healthy individuals were included in this crosssectional study. Blood samples were taken in the first 24 h of the attack periods. Serum soluble CXCL16 was evaluated by enzyme-linked immunosorbent assay (ELISA) method. Results: CXCL16 (P < 0.001), erythrocyte sedimentation rate (P < 0.001), C-reactive protein (P < 0.001), and fibrinogen (P = 0.005) were significantly higher in FMF group than in control group. Receiver operating characteristic (ROC) curve analysis revealed a cut off value of CXCL16 as 2.68 ng/ml with 83% sensitivity and 68% specificity (P < 0.001). Logistic regression analysis indicated that high CXCL16 and erythrocyte sedimentation rate levels were predictive parameters for FMF disease (OR 8.31; 95% CI 2.59-26.62; p

PDF

___

1. Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nature Reviews Rheumatology 2014; 10: 135-147. doi: 10.1038/nrrheum.2013.174
2. Alghamdi M. Familial Mediterranean fever, review of the literature. Clinical Rheumatology 2017; 36 (8): 1707‐1713. doi:10.1007/s10067-017-3715-5
3. Özen S, Batu ED, Demir S. Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management. Frontiers in Immunology 2017; 8: 253. doi:10.3389/fimmu.2017.00253
4. Ozdogan H, Ugurlu S. Familial Mediterranean fever. Presse Medicale (Paris, France : 1983) 2019; 48(1 Pt 2): e61‐e76. doi:10.1016/j.lpm.2018.08.014 5. Kucuk A, Gezer IA, Ucar R, Karahan AY. Familial Mediterranean fever. Acta Medica (Hradec Kralove) 2014; 57 (3): 97‐104. doi:10.14712/18059694.2014.47
6. Van Gorp H, Huang L, Saavedra P, Vuylsteke M, Asaoka T et al. Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. Annals of the Rheumatic Diseases 2020; 79 (7): 960-968. doi:10.1136/annrheumdis-2019-216701
7. Toplak N, Frenkel J, Ozen S, Lachmann HJ, Woo P et al. An international registry on autoinflammatory diseases: the Eurofever experience. Annals of the Rheumatic Diseases 2012; 71 (7): 1177-1182. doi:10.1136/annrheumdis-2011-200549
8. Hassan AM, Farghal NMA, Hegab DS, Mohamed WS, Abd-Elnabi HH. Serum-soluble CXCL16 in juvenile systemic lupus erythematosus: a promising predictor of disease severity and lupus nephritis. Clinical Rheumatology 2018; 37(11): 3025‐3032. doi:10.1007/s10067-018-4203-2
9. Lehrke M, Konrad A, Schachinger V, Tillack C, Seibold F et al. CXCL16 is a surrogate marker of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2008; 43(3): 283‐288. doi:10.1080/00365520701679249
10. Yilmaz S, Cinar M, Pekel A, Simsek I, Musabak U et al. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet’s disease. Clinical and Experimental Rheumatology 2013; 31(3 Suppl 77): 84‐87
11. Gong Q, Wu F, Pan X, Yu J, Li Y et al. Soluble C-X-C chemokine ligand 16 levels are increased in gout patients. Clinical Biochemistry 2012; 45(16-17): 1368-1373. doi: 10.1016/j.clinbiochem.2012.05.014
12. Qin M, Guo Y, Jiang L, Wang X. Elevated levels of serum sCXCL16 in systemic lupus erythematosus; potential involvement in cutaneous and renal manifestations. Clinical Rheumatology 2014; 33(11): 1595‐1601. doi:10.1007/s10067-014-2741-9
13. Elemam NM, Hannawi S, Maghazachi AA. Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis. Immuno Targets and Therapy 2020; 9:43‐56. doi:10.2147/ITT.S243636
14. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nature Immunology 2000; 1 (4): 298-304. doi:10.1038/79738
15. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. Journal of Immunology 2004; 172 (10): 6362-6372. doi:10.4049/jimmunol.172.10.6362
16. van der Voort R, van Lieshout AW, Toonen LW, Slöetjes AW, van den Berg WB et al. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. Arthritis and Rheumatism 2005; 52 (5): 1381-1391. doi:10.1002/art.21004
17. Gok M, Sirkeci O, Kara M, Sakin YS, Tanoglu A et al. Evaluation of pentraxin-3 in familial Mediterranean fever patients during attack and attack-free periods. Bratislavske Lekarske Listy 2018; 119 (8): 490-493. doi:10.4149/BLL_2018_089
18. Erer B, Demirkaya E, Ozen S, Kallinich T. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatology International 2016; 36 (4): 483‐487. doi:10.1007/s00296-015-3413-z
19. Çakan M, Aktay Ayaz N, Keskindemirci G, Karadağ ŞG, Tanatar A et al. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections. Clinical Rheumatology 2020; 39 (1): 249‐253. doi:10.1007/ s10067-019-04765-1
20. Krainer J, Siebenhandl S, Weinhäusel A. Systemic autoinflammatory diseases. Journal of Autoimmunity 2020; 109: 102421. doi:10.1016/j.jaut.2020.102421
21. Funk T, Fuchs AR, Altdörfer VS, Klein R, Autenrieth SE et al. Monocyte-derived dendritic cells display a highly activated phenotype and altered function in patients with familial Mediterranean fever. Clinical and Experimental Immunology 2020; 201(1): 1-11. doi:10.1111/cei.13439
22. Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N et al. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. Journal of Immunology 2007; 179: 7166- 7175
23. Lopes LR, Ribeiro SMLT, Figueiredo VP, Leite ALJ, Nicolato RLC et al. The overweight increases circulating inflammatory mediators commonly associated with obesity in young individuals. Cytokine 2018; 110:169‐173. doi:10.1016/j. cyto.2018.04.024
24. Oncu K, Yazgan Y, Tanoglu A, Kaplan M, Ermis F et al. Can serum fetuin-A be regarded as an inflammatory marker among patients with familial Mediterranean fever? Digestive Diseases and Sciences 2013; 58 (11): 3212-7. doi: 10.1007/s10620-013- 2814-7
25. Asan G, Derin ME, Doğan HO, Bayram M, Şahin M et al. Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients? Journal of Korean Medical Science 2020; 35 (10): e63. doi: 10.3346/jkms.2020.35.e63
26. Çakan M, Aktay Ayaz N, Keskindemirci G, Karadağ ŞG, Tanatar A et al. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections. Clinical Rheumatology 2020; 39 (1): 249-253. doi: 10.1007/s10067-019-04765-1
27. Yel S, Dursun İ, Çetin F, Baştuğ F, Tülpar S et al. Increased circulating endothelial microparticles in children with FMF. Biomarkers 2018; 23 (6): 558-562. doi: 10.1080/1354750X.2018.1460764
28. Ozalper V, Kara M, Tanoglu A, Cetındaglı I, Ozturker C et al. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation. Clinical Rheumatology 2017; 36 (9): 2071-2077. doi: 10.1007/s10067-016-3532-2
29. Doğan HO, Omma A, Turhan T, Boğdaycıoğlu N, Karaaslan Y et al. Decreased Chitotriosidase Activity and Levels in Familial Mediterranean Fever. Journal of Korean Medical Science 2016; 31 (12): 1902-1906. doi: 10.3346/jkms.2016.31.12.1902
30. Dinç M, Tanoğlu A, Yazgan Y, Beyazıt Y, Öncü K et al. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in patients with familial Mediterranean fever. Turkish Journal of Gastroenterolology 2015; 26 (6): 487- 91. doi: 10.5152/tjg.2015.0223
31. Taylan A, Gurler O, Toprak B, Sisman AR, Yalcin H et al. S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever. Journal of Korean Medical Science 2015; 30 (9): 1241-5. doi: 10.3346/ jkms.2015.30.9.1241